fluorodeoxyglucose f18 has been researched along with Scleroderma, Diffuse in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dobashi, H; Kameda, T; Nishiyama, Y; Yamamoto, Y | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Scleroderma, Diffuse
| Article | Year |
|---|---|
Clinical value of 18F-fluorodeoxyglucose positron emission tomography in patients with connective tissue disease.
Topics: Adult; Aged; Arthritis, Rheumatoid; Connective Tissue; Connective Tissue Diseases; Dermatomyositis; Female; Fluorodeoxyglucose F18; Granulomatosis with Polyangiitis; Humans; Imaging, Three-Dimensional; Lupus Erythematosus, Systemic; Male; Middle Aged; Polymyositis; Positron-Emission Tomography; Radiopharmaceuticals; Scleroderma, Diffuse; Takayasu Arteritis | 2010 |